WO1990005523A3 - Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase - Google Patents
Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase Download PDFInfo
- Publication number
- WO1990005523A3 WO1990005523A3 PCT/US1989/004774 US8904774W WO9005523A3 WO 1990005523 A3 WO1990005523 A3 WO 1990005523A3 US 8904774 W US8904774 W US 8904774W WO 9005523 A3 WO9005523 A3 WO 9005523A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- phenanthrolinedicarboxylate
- aminoquinoline
- esters
- inhibitors
- reverse transcriptase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27156788A | 1988-11-15 | 1988-11-15 | |
US271,567 | 1988-11-15 | ||
US27936488A | 1988-12-02 | 1988-12-02 | |
US279,364 | 1988-12-02 | ||
US28744888A | 1988-12-20 | 1988-12-20 | |
US287,448 | 1988-12-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1990005523A2 WO1990005523A2 (en) | 1990-05-31 |
WO1990005523A3 true WO1990005523A3 (en) | 1990-07-12 |
Family
ID=27402391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1989/004774 WO1990005523A2 (en) | 1988-11-15 | 1989-10-30 | Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4488989A (en) |
CA (1) | CA2002414A1 (en) |
WO (1) | WO1990005523A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3002700B2 (en) * | 1990-08-29 | 2000-01-24 | 化研生薬株式会社 | Anti-AIDS virus agent |
WO1992016508A1 (en) * | 1991-03-14 | 1992-10-01 | The Upjohn Company | Reissert compounds as anti-hiv agents |
WO1992018123A2 (en) * | 1991-04-10 | 1992-10-29 | Octamer, Inc. | A method for inhibition of retroviral replication |
DE4344452A1 (en) * | 1993-12-24 | 1995-06-29 | Hoechst Ag | Aza-4-iminoquinolines, process for their preparation and their use |
ATE334975T1 (en) | 1997-05-30 | 2006-08-15 | Takeda Pharmaceutical | SULFONAMIDE DERIVATIVES, THEIR PRODUCTION AND USE |
CA2317017A1 (en) | 1998-02-05 | 1999-08-12 | Takeda Chemical Industries, Ltd. | Sulfonamide derivatives, their production and use |
JP6740354B2 (en) | 2015-10-05 | 2020-08-12 | ザ トラスティーズ オブ コロンビア ユニバーシティー イン ザ シティー オブ ニューヨーク | Activator of autophagy flow and clearance of protein aggregates containing phospholipase D and tau and method for treating proteinosis |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3790577A (en) * | 1970-10-05 | 1974-02-05 | Ici Ltd | Pyridoquinoline dicarboxylic acid derivatives |
-
1989
- 1989-10-30 AU AU44889/89A patent/AU4488989A/en not_active Abandoned
- 1989-10-30 WO PCT/US1989/004774 patent/WO1990005523A2/en not_active Application Discontinuation
- 1989-11-07 CA CA 2002414 patent/CA2002414A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3790577A (en) * | 1970-10-05 | 1974-02-05 | Ici Ltd | Pyridoquinoline dicarboxylic acid derivatives |
Non-Patent Citations (1)
Title |
---|
Chemical Abstracts, vol. 104, no. 11, 17 March 1986,(Columbus, Ohio, US), Z. Szulc et al: "The syntheses and properties of tricyclic azines as potential interferon inducers and antivirus agents", see page 650, abstract 88460z, & Stud. Org. Chem. (Amsterdam) 1984, 18 (Bio-Org. Heterocycl.), 363-6 * |
Also Published As
Publication number | Publication date |
---|---|
CA2002414A1 (en) | 1990-05-15 |
AU4488989A (en) | 1990-06-12 |
WO1990005523A2 (en) | 1990-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2452288A (en) | Nucleoside derivatives useful in treating retroviral infections | |
MX9203543A (en) | MEDICINE. | |
HK1011025A1 (en) | 5,11-Dihydro-6h-dipyrido¬3,2-b:2'3'-e¾¬1,4¾diazepines and their use in the preventionor treatment of hiv infection | |
AU1189688A (en) | Utilization of morphine antagonists in the preparation of drugs having an immunomodulator and antiviral effect, particularly for treating acquired immunodeficiency states | |
DK92788A (en) | USE OF 3'-DEOXY-3'-FLUORUANOSIDES FOR THE PREPARATION OF MEDICINAL PRODUCTS AGAINST RETROVIRA | |
AU1968992A (en) | Preparation of fatty acid medicaments | |
EP0369887A3 (en) | Use of trifluoromethyl phenyl-tetrahydropyridines in the manufacture of a medicament for the treatment of anxio-depressive disorders | |
DK284189A (en) | PHARMACEUTICAL PRODUCTS | |
UA19756A1 (en) | Process for preparation of piperazinyle-alkyl-3(2n)pyridazinones or pharmaceutically acceptable salts thereof | |
WO1990005523A3 (en) | Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase | |
EP0328924A3 (en) | Thienotriazolodiazepine compounds and pharmaceutical uses thereof | |
BG50159A3 (en) | Method for preparing derivatives of piranobenzadiasole | |
RU94045248A (en) | Method for inhibition of activation of virus of human immunodefficiency in vivo | |
DE3856052D1 (en) | Use of the N-n-butyl derivative of deoxynojirimycin in the manufacture of a medicament for inhibiting the HIV virus | |
WO2000043014A3 (en) | Beta-d-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine for use in the treatment of hiv infections | |
WO1997026880A3 (en) | Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients | |
HU9501218D0 (en) | Use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection | |
WO1998044913A3 (en) | Compositions containing mkc-442 in combination with other antiviral agents | |
EP1731155A3 (en) | Beta-d-2', 3' -didehydro-2', 3' -dideoxy-5-fluorocytidine for use in the treatment of hiv infections | |
AU2880495A (en) | Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
DK0457336T3 (en) | New use of 4-carbamoyl-1-beta-D-ribofuranosylimidazolium-5-olate | |
AU7111587A (en) | Perhydrothiazepine and perhydroazepine derivatives,their preparation and their therapeutic use | |
Brossi | De bello physostigminico II | |
WO1988008707A3 (en) | Rubradirin derivatives for treatment of hiv infection | |
EP0370821A3 (en) | 1,4-dihydropyridine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 1989912025 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU DK FI HU JP KR NO SU US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU DK FI HU JP KR NO SU US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1989912025 Country of ref document: EP |